Last 12 months
Inside the activity.
0 purchase rows · 40 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2023 Filed Aug 22, 2023 20:50 UTC |
Sullivan William MDirector
|
SaleCommon Stock, $0.01 par value per share | 18,153 | $25.06 | $454,914.18 |
DisclosureSEC source: 0001759655-23-000196 · wk-form4_1692737394.xml · nonDerivative · entry 1 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brighton Family, LLC Disclosed balance after: 5,546,790 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.88 to $25.17 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 04, 2023 Filed Aug 8, 2023 20:55 UTC |
Sullivan William MDirector
|
SaleCommon Stock, $0.01 par value per share | 14,003 | $27.28 | $382,001.84 |
DisclosureSEC source: 0001759655-23-000194 · wk-form4_1691528039.xml · nonDerivative · entry 2 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brighton Family, LLC Disclosed balance after: 5,564,943 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.93 to $27.50 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 04, 2023 Filed Aug 8, 2023 20:55 UTC |
Sullivan William MDirector
|
SaleCommon Stock, $0.01 par value per share | 4,150 | $26.49 | $109,933.50 |
DisclosureSEC source: 0001759655-23-000194 · wk-form4_1691528039.xml · nonDerivative · entry 1 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brighton Family, LLC Disclosed balance after: 5,578,946 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.93 to $26.92 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:42 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 15,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000192 · wk-form4_1691440922.xml · derivative · entry 5 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,784 Underlying: Common Stock · 15,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: All stock options are fully vested and exercisable. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:42 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 66 | $27.71 | $1,828.86 |
DisclosureSEC source: 0001759655-23-000192 · wk-form4_1691440922.xml · nonDerivative · entry 4 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,114 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2022. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.71 to $27.73 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:42 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 4,300 | $27.02 | $116,186.00 |
DisclosureSEC source: 0001759655-23-000192 · wk-form4_1691440922.xml · nonDerivative · entry 3 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,180 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2022. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.67 to $27.64 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:42 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 10,634 | $26.30 | $279,674.20 |
DisclosureSEC source: 0001759655-23-000192 · wk-form4_1691440922.xml · nonDerivative · entry 2 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,480 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.64 to $26.63 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:42 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.01 par value per share | 15,000 | $2.00 | $30,000.00 |
DisclosureSEC source: 0001759655-23-000192 · wk-form4_1691440922.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:31 UTC |
WICHMANN DAVID SDirector
|
GrantCommon Stock, par value $0.01 per share | 6,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001268489-23-000010 · wk-form4_1691094703.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,189 F2 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the day immediately preceding the date of Company's 2024 Annual Meeting of Stockholders. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:28 UTC |
Kimmet Pamela ODirector
|
GrantCommon Stock, par value $0.01 per share | 6,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001589981-23-000015 · wk-form4_1691094484.xml · nonDerivative · entry 1 Kimmet Pamela O · CIK 0001589981 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,189 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the day immediately preceding the date of Company's 2024 Annual Meeting of Stockholders. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:56 UTC |
Mehrotra ParthDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 31,744 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000183 · wk-form4_1691009795.xml · derivative · entry 3 Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,672 Underlying: Common Stock · 31,744 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: All stock options are fully vested and exercisable. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:56 UTC |
Mehrotra ParthDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 31,744 | $28.03 | $889,784.32 |
DisclosureSEC source: 0001759655-23-000183 · wk-form4_1691009795.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,974 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.10 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:56 UTC |
Mehrotra ParthDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 31,744 | $2.00 | $63,488.00 |
DisclosureSEC source: 0001759655-23-000183 · wk-form4_1691009795.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2023 Filed Jul 25, 2023 20:30 UTC |
Sullivan William MDirector
|
SaleCommon Stock, $0.01 par value per share | 18,153 | $26.82 | $486,863.46 |
DisclosureSEC source: 0001759655-23-000175 · wk-form4_1690317004.xml · nonDerivative · entry 1 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brighton Family, LLC Disclosed balance after: 5,583,096 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.49 to $27.12 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:42 UTC |
Mehrotra ParthDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 12,414 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000173 · wk-form4_1689975744.xml · derivative · entry 3 Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136,416 Underlying: Common Stock · 12,414 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: All stock options are fully vested and exercisable. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:42 UTC |
Mehrotra ParthDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 12,414 | $28.06 | $348,336.84 |
DisclosureSEC source: 0001759655-23-000173 · wk-form4_1689975744.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,974 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.20 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:42 UTC |
Mehrotra ParthDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 12,414 | $2.00 | $24,828.00 |
DisclosureSEC source: 0001759655-23-000173 · wk-form4_1689975744.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 166,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2023 Filed Jul 11, 2023 21:24 UTC |
Sullivan William MDirector
|
SaleCommon Stock, $0.01 par value per share | 600 | $25.69 | $15,414.00 |
DisclosureSEC source: 0001759655-23-000171 · wk-form4_1689110676.xml · nonDerivative · entry 2 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brighton Family, LLC Disclosed balance after: 5,601,249 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.67 to $25.72 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting persons disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 07, 2023 Filed Jul 11, 2023 21:24 UTC |
Sullivan William MDirector
|
SaleCommon Stock, $0.01 par value per share | 17,553 | $24.99 | $438,649.47 |
DisclosureSEC source: 0001759655-23-000171 · wk-form4_1689110676.xml · nonDerivative · entry 1 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brighton Family, LLC Disclosed balance after: 5,601,849 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.60 to $25.56 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting persons disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:34 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 15,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000158 · wk-form4_1688675658.xml · derivative · entry 3 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,784 Underlying: Common Stock · 15,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: All stock options are fully vested and exercisable. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:34 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 15,000 | $25.68 | $385,200.00 |
DisclosureSEC source: 0001759655-23-000158 · wk-form4_1688675658.xml · nonDerivative · entry 2 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,114 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.39 to $26.11 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:34 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.01 par value per share | 15,000 | $2.00 | $30,000.00 |
DisclosureSEC source: 0001759655-23-000158 · wk-form4_1688675658.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:28 UTC |
Ryu JaewonDirector
|
GrantCommon Stock, $0.01 par value per share | 7,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000149 · wk-form4_1688588889.xml · nonDerivative · entry 1 Ryu Jaewon · CIK 0001869233 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,127 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 16:31 UTC |
Maryland Patricia AnneDirector
|
GrantCommon Stock, $0.01 par value per share | 7,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000154 · wk-form4_1688589039.xml · nonDerivative · entry 1 Maryland Patricia Anne · CIK 0001798468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,792 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:30 UTC |
COCOZZA NANCY GDirector
|
GrantCommon Stock, $0.01 par value per share | 7,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000153 · wk-form4_1688589018.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,831 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:29 UTC |
KING DAVID PDirector
|
GrantCommon Stock, $0.01 par value per share | 7,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000151 · wk-form4_1688588962.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,792 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:31 UTC |
McCarthy Thomas ADirector
|
GrantCommon Stock, $0.01 par value per share | 7,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000152 · wk-form4_1688589007.xml · nonDerivative · entry 1 McCarthy Thomas A · CIK 0001500886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,487 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:28 UTC |
Sullivan William MDirector
|
GrantCommon Stock, $0.01 par value per share | 7,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000150 · wk-form4_1688588924.xml · nonDerivative · entry 1 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,792 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:27 UTC |
Mehrotra ParthPresident and COO
|
GrantCommon Stock, $0.01 par value per share | 15,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000148 · wk-form4_1688588830.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,974 F1 · shares: On July 1, 2023, the reporting person received 15,571 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 21:06 UTC |
Sullivan William MDirector
|
SaleCommon Stock, $0.01 par value per share | 5,638 | $25.08 | $141,401.04 |
DisclosureSEC source: 0001759655-23-000140 · wk-form4_1688072771.xml · nonDerivative · entry 1 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brighton Family, LLC Disclosed balance after: 5,619,402 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.01 to $25.13 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 26, 2023 Filed Jun 27, 2023 21:26 UTC |
Sullivan William MDirector
|
SaleCommon Stock, $0.01 par value per share | 400 | $25.01 | $10,004.00 |
DisclosureSEC source: 0001759655-23-000135 · wk-form4_1687901188.xml · nonDerivative · entry 2 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brighton Family, LLC Disclosed balance after: 5,625,040 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.01 to $25.02 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 21:26 UTC |
Sullivan William MDirector
|
SaleCommon Stock, $0.01 par value per share | 12,115 | $24.55 | $297,423.25 |
DisclosureSEC source: 0001759655-23-000135 · wk-form4_1687901188.xml · nonDerivative · entry 1 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brighton Family, LLC Disclosed balance after: 5,625,440 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.16 to $24.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 20:39 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 173,633 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000131 · wk-form4_1686775168.xml · derivative · entry 7 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,045,965 Underlying: Common Stock · 173,633 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: All stock options are fully vested and exercisable. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 20:39 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 10,531 | $29.18 | $307,294.58 |
DisclosureSEC source: 0001759655-23-000131 · wk-form4_1686775168.xml · nonDerivative · entry 5 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,645 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.03 to $29.40 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 20:39 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 163,102 | $28.55 | $4,656,562.10 |
DisclosureSEC source: 0001759655-23-000131 · wk-form4_1686775168.xml · nonDerivative · entry 4 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,176 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.01 to $28.98 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 20:39 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 173,633 | $2.00 | $347,266.00 |
DisclosureSEC source: 0001759655-23-000131 · wk-form4_1686775168.xml · nonDerivative · entry 3 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 279,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 20:39 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 162,168 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000131 · wk-form4_1686775168.xml · derivative · entry 6 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,219,598 Underlying: Common Stock · 162,168 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: All stock options are fully vested and exercisable. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 20:39 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 162,168 | $28.46 | $4,615,301.28 |
DisclosureSEC source: 0001759655-23-000131 · wk-form4_1686775168.xml · nonDerivative · entry 2 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,645 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.96 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 20:39 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 162,168 | $2.00 | $324,336.00 |
DisclosureSEC source: 0001759655-23-000131 · wk-form4_1686775168.xml · nonDerivative · entry 1 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 20:42 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 91,605 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000127 · wk-form4_1686602539.xml · derivative · entry 6 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 148,830 Underlying: Common Stock · 91,605 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All stock options are fully vested and exercisable. Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 20:42 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 91,605 | $28.36 | $2,597,917.80 |
DisclosureSEC source: 0001759655-23-000127 · wk-form4_1686602539.xml · nonDerivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,457 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.56 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 20:42 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 91,605 | $2.00 | $183,210.00 |
DisclosureSEC source: 0001759655-23-000127 · wk-form4_1686602539.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 230,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 21:13 UTC |
Sullivan William MDirector
|
SaleCommon Stock, $0.01 par value per share | 18,153 | $28.35 | $514,637.55 |
DisclosureSEC source: 0001759655-23-000129 · wk-form4_1686690793.xml · nonDerivative · entry 1 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brighton Family, LLC Disclosed balance after: 5,637,555 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.62 to $28.59 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:42 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 8,395 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000127 · wk-form4_1686602539.xml · derivative · entry 5 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 240,435 Underlying: Common Stock · 8,395 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All stock options are fully vested and exercisable. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:42 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 8,395 | $28.00 | $235,060.00 |
DisclosureSEC source: 0001759655-23-000127 · wk-form4_1686602539.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,457 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.01 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:42 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 8,395 | $2.00 | $16,790.00 |
DisclosureSEC source: 0001759655-23-000127 · wk-form4_1686602539.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 21:08 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 15,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000125 · wk-form4_1686344924.xml · derivative · entry 3 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,784 Underlying: Common Stock · 15,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: All stock options are fully vested and exercisable. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 21:08 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 15,000 | $25.38 | $380,700.00 |
DisclosureSEC source: 0001759655-23-000125 · wk-form4_1686344924.xml · nonDerivative · entry 2 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,114 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.61 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 21:08 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.01 par value per share | 15,000 | $2.00 | $30,000.00 |
DisclosureSEC source: 0001759655-23-000125 · wk-form4_1686344924.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 21:06 UTC |
Sullivan William MDirector
|
SaleCommon Stock, $0.01 par value per share | 985 | $25.04 | $24,664.40 |
DisclosureSEC source: 0001759655-23-000123 · wk-form4_1686344807.xml · nonDerivative · entry 1 Sullivan William M · CIK 0001859839 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brighton Family, LLC Disclosed balance after: 5,655,708 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022. F2 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.